Cure My Disease

Don't miss your cure!

 Log in / Sign up

Elastic bands vs. inflatable cuffs: can cheap flossing bands restrict blood flow safely?

NCT ID NCT06075901

Knowledge-focused Sponsor: Paulista University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 16, 2026 · Last updated Sep 17, 2026 · Updated 1 time

Summary

Researchers are studying whether tissue flossing, an elastic band wrapped around the leg, can reliably restrict blood flow during low-intensity resistance training. The trial compares tissue flossing with a standard inflatable blood flow restriction cuff in 136 participants. Over four weeks, participants do leg exercises three times a week while researchers measure blood flow, muscle properties, and perceived discomfort. The goal is to see if tissue flossing is a dependable and affordable alternative to traditional cuffs.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Tissue flossing, an elastic band wrapped around the leg to apply pressure, compared with a standard inflatable blood flow restriction cuff
What this could lead to
If tissue flossing proves reliable, it could give people a low-cost way to add blood flow restriction to light exercise, which may help build muscle and strength without heavy weights.
What could go wrong
The study is small and early, so it may not show that tissue flossing works as consistently as standard cuffs. Applying pressure bands incorrectly can cause discomfort or bruising, and the results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 136 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 30 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals who present one or more of the following characteristics will not be included: * 1 presence of any health condition that contraindicates or prevents exercise; * 2 diabetes and diagnosed high blood pressure; * 3 inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker; * 5 history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent lower limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months); * 6 use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications; * 7 having one or more risk factors predisposing to thromboembolism Exclusion Criteria: * Participants will be excluded from the study if they: * 1 have a health problem that does not allow them to continue; * 2 wish to leave the study; * 3 not sign the consent form

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertrophy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypertrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypertrophy Muscle strength

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Franciele Marques Vanderlei

    Presidente Prudente, São Paulo, 55, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.